000 | 03273nam a22005535i 4500 | ||
---|---|---|---|
001 | 978-3-030-61507-9 | ||
003 | DE-He213 | ||
005 | 20211012192423.0 | ||
007 | cr nn 008mamaa | ||
008 | 201203s2020 gw | s |||| 0|eng d | ||
020 |
_a9783030615079 _9978-3-030-61507-9 |
||
024 | 7 |
_a10.1007/978-3-030-61507-9 _2doi |
|
050 | 4 | _aQP34-38 | |
072 | 7 |
_aMFG _2bicssc |
|
072 | 7 |
_aMED075000 _2bisacsh |
|
072 | 7 |
_aMFG _2thema |
|
082 | 0 | 4 |
_a612 _223 |
245 | 1 | 0 |
_aReviews of Physiology, Biochemistry and Pharmacology _h[electronic resource] / _cedited by Stine Helene Falsig Pedersen. |
250 | _a1st ed. 2020. | ||
264 | 1 |
_aCham : _bSpringer International Publishing : _bImprint: Springer, _c2020. |
|
300 |
_aVII, 110 p. _bonline resource. |
||
336 |
_atext _btxt _2rdacontent |
||
337 |
_acomputer _bc _2rdamedia |
||
338 |
_aonline resource _bcr _2rdacarrier |
||
347 |
_atext file _bPDF _2rda |
||
490 | 1 |
_aReviews of Physiology, Biochemistry and Pharmacology, _x0303-4240 ; _v178 |
|
505 | 0 | _a1. CXC Chemokine Receptors in the Tumor Microenvironment and an Update of Antagonist Development -- 2. Molecular Mechanisms of Fuchs and Congenital Hereditary Endothelial Corneal Dystrophies -- 3. Promising Anti-Atherosclerotic Effect of Berberine; Evidence from in Vitro, in Vivo, and Clinical Studies -- 4. Ion channels in glioma malignancy. . | |
520 | _aCXC Chemokine Receptors in the Tumor Microenvironment and an Update of Antagonist Development Yang Xun, Hua Yang, Jiekai Li, Fuling Wu, and Fang Liu Molecular Mechanisms of Fuchs and Congenital Hereditary Endothelial Corneal Dystrophies Darpan Malhotra and Joseph R. Casey Promising Anti-Atherosclerotic Effect of Berberine; Evidence from in Vitro, in Vivo, and Clinical Studies Alireza Fatahian, Saeed Mohammadian Haftcheshmeh, Sara Azhdari, Helaleh Kaboli Farshchi, Banafsheh Nikfar, and Amir Abbas Momtazi-Borojeni Ion channels in glioma malignancy Luigi Catacuzzeno, Luigi Sforna, Vincenzo Esposito, Cristina Limatola, and Fabio Franciolini. | ||
650 | 0 | _aHuman physiology. | |
650 | 0 | _aMedical biochemistry. | |
650 | 0 | _aProteins . | |
650 | 0 | _aPharmacology. | |
650 | 1 | 4 |
_aHuman Physiology. _0https://scigraph.springernature.com/ontologies/product-market-codes/B13004 |
650 | 2 | 4 |
_aMedical Biochemistry. _0https://scigraph.springernature.com/ontologies/product-market-codes/H35005 |
650 | 2 | 4 |
_aProtein Science. _0https://scigraph.springernature.com/ontologies/product-market-codes/L14040 |
650 | 2 | 4 |
_aPharmacology/Toxicology. _0https://scigraph.springernature.com/ontologies/product-market-codes/B21007 |
700 | 1 |
_aPedersen, Stine Helene Falsig. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
710 | 2 | _aSpringerLink (Online service) | |
773 | 0 | _tSpringer Nature eBook | |
776 | 0 | 8 |
_iPrinted edition: _z9783030615062 |
776 | 0 | 8 |
_iPrinted edition: _z9783030615086 |
776 | 0 | 8 |
_iPrinted edition: _z9783030615093 |
830 | 0 |
_aReviews of Physiology, Biochemistry and Pharmacology, _x0303-4240 ; _v178 |
|
856 | 4 | 0 | _uhttps://doi.org/10.1007/978-3-030-61507-9 |
912 | _aZDB-2-SBL | ||
912 | _aZDB-2-SXB | ||
950 | _aBiomedical and Life Sciences (SpringerNature-11642) | ||
950 | _aBiomedical and Life Sciences (R0) (SpringerNature-43708) | ||
999 |
_c553269 _d553204 |